Synthroid (levothyroxine Sodium Tablets, Usp) Trademark Details

Synthroid (Levothyroxine Sodium Tablets, Usp) was registered on Tuesday, January 4, 2000 and is currently owned by Knoll Pharmaceutical Company under the registration number 2305939 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 17 years ago on Saturday, October 7, 2006, according to the United State Patent & Trademark Office
Word Mark Synthroid (Levothyroxine Sodium Tablets, Usp)
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Knoll Pharmaceutical Company of Abbott Park, IL

View all trademarks for Knoll Pharmaceutical Company
Other Trademarks for Knoll Pharmaceutical Company
Serial Number 75568800
Registration Number 2305939
Status Date Saturday, October 7, 2006
Filing Date Saturday, October 7, 2006
Registration Date Tuesday, January 4, 2000
Attorney Jacqueline M. Ostroski

Correspondent

JACQUELINE M. OSTROSKI
BASF CORPORATION
3000 CONTINENTAL DRIVE NORTH
MOUNT OLIVE, NEW JERSEY 07828- 1234

Case File Statements

Disclaimer with Predetermined Text "(LEVOTHYROXINE SODIUM TABLETS, USP)" and of the representation of the human thyroid
Goods & Services Synthetic Thyroxine for Treatment of Myxedema, Cretinism, and Various Other Hypometabolic States
Lining/Stippling Statement The mark is lined for the colors brown (flesh) and blue.

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Saturday, October 7, 2006
First Use Anywhere Thursday, September 17, 1998
First Use In Commerce Thursday, September 17, 1998
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.